Overview

Effect of RECK in Posterior Spinal Fusion

Status:
WITHDRAWN
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
"RECK" is a combination of local anesthesia medications, used for the purpose of pain control. RECK is an acronym which stands for Ropivacaine, Epinephrine, Clonidine, and Ketorolac. The purpose of this study is to investigate the effect of RECK local injectable anesthetic in the setting of posterior spinal fusion. Our specific aims are the following. Primary aim: to investigate the effect of RECK local injectable anesthetic on postoperative VAS pain scores. Secondary aims: to investigate of effect of RECK injection on postoperative opioid consumption and hospital length of stay. Hypothesis: RECK injection will significantly decrease postoperative VAS pain score, opioid consumption, and hospital length of stay compared to placebo controls.
Phase:
PHASE1
Details
Lead Sponsor:
University of Maryland, Baltimore
Treatments:
Clonidine
Epinephrine
Ropivacaine